New drug MH-001 put to the test in healthy humans for first time
Knowledge-focused
Completed
This early-stage study tested the safety of a new drug, MH-001, in 58 healthy adults. Participants received either single or multiple doses of the drug or a placebo. The main goal was to check for side effects and measure how the drug moves through the body. No treatment benefit …
Phase: PHASE1 • Sponsor: Vespina Lifesciences Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC